CompoAtlas

VITAMINE C 500 mg

Food supplement declared in France, declaration No 2022-1-575

VITAMINE C 500 mg (ORFITO) is a food supplement declared in France. Status: retrait du marché annoncé pour le 2 July 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked. Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.

Brand
ORFITO
Food business operator placing the product on the market
BioUltime
Status
Retrait du marché annoncé pour le 2 July 2027
Form
Gélule
Daily dose
1 gélule par jour
Directions for use
1 gélule au petit déjeuner ou au déjeuner au milieu du repas.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Enfants (moins de 12 ans)

Declaration 165121, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Malpighia glabra L.FruitExtrait sec aqueux50 mg
Rosa canina L.FruitPoudre (de plantes séchées ou broyées)50 mg

Other active ingredients

NamePer day
Citroflavonoïdesnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
L-ascorbate de calciumVitamine Cpas de limite (données insuffisantes)180 mg

The product name states 500 mg of vitamine C per serving, above the maximum dose of 180 mg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label.

Additives

E470b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Femmes enceintes ou allaitantes, consulter un professionnel de santé avant utilisation. Déconseillé aux adolescents et aux enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : ORFITO

Enter to analyse, Shift+Enter for a new line